The cannabis plant contains hundreds of substances (cannabinoids and terpenes), and each one—or each combination of them—can have different medical effects. One of the challenges in transforming cannabis into a pharmaceutical drug is the natural variation in its cultivation. This means the flowers have varying compositions, unlike the uniform well defined and robust products of the pharmaceutical industry. Cannabis reform will result in that the products being sold in pharmacies having accurate and precise doses of the active ingredients as required for typical drug.
Aminocann, a subsidiary company of Aminolab, provides a complete response to the Israeli Cannabis market
Aminocann provides solutions that answer the requirements of the Cannabis reform in Israel for both farmers and manufacturers.
Aminocann operates through Aminolab to provide analytical laboratory services while complying with the latest standards for cannabis manufacturers, certified by the National Laboratory Accreditation Authority and recognized by the Ministries of Health and Agriculture.